DUX4 and Facioscapulohumeral dystrophy: Finally, we validated previous studies showing that miR-675 could be increased by estrogen/progesterone and melatonin, and then used these small molecules to upregulate endogenous miR-675 and decrease DUX4 and DUX4-responsive biomarkers in human FSHD myotubes.